XML 140 R63.htm IDEA: XBRL DOCUMENT
v3.26.1

Interests in equity-accounted investees (Tables) | 12 Months Ended
--- | ---
Dec. 31, 2025
Disclosure of associates [abstract] |
Summary of detailed information about interest in joint venture and associates |
| 2025 |  | 2024
Interests in associates | $ | 66,109 |  |  | $ | 68,223 |
Summary of interests in equity accounted investees | Particulars of equity-accounted investees of the Group are as follows:
Name of an equity-accounted investee | Place of incorporation/ operation |  | Particular of issued and paid-up capital |  | Proportion of nominal value of issue capital held by the Company |  | Principal activity
|  |  |  |  | 2025 |  | 2024 |  |
|  |  |  |  | Directly |  | Indirectly |  | Directly |  | Indirectly |  |
|  |  |  |  | % |  | % |  | % |  | % |  |
Insighta | Cayman Islands |  | 2,000,000 ordinary shares |  | 35 |  |  | — |  |  | 35 |  |  | — |  |  | Multi-cancer genetic testing services
CERBACT Asia Holdings Pte. Ltd. (“CERBACT”) | Singapore |  | 100 ordinary shares |  | — |  |  | — |  |  | — |  |  | 26.04 |  |  | Investment holdings
The following table summarizes the financial information of Insighta, for the years ended December 31, 2025 and 2024, as included in its own financial statements, adjusted for fair value adjustments at acquisition and differences in accounting policies. The table also reconciles the summarized financial information to the carrying amount of the Group's interest in Insighta recognized in the consolidated financial statements.
| 2025 |  | 2024
Non-current assets | $ | 122,253 |  |  | $ | 127,005 |
Current assets (including cash and cash equivalents $80,153 (2024: $81,005)) | 80,568 |  |  | 81,388 |
Non-current liabilities | (13,513) |  |  | (14,417) |
Other payables, accruals and contract liabilities | (316) |  |  | (238) |
Amount due to a related company | (110) |  |  | (1,179) |
Equity | $ | 188,882 |  |  | $ | 192,559 |
Proportion of the Group’s interest in the associate | 35 | % |  | 35 | %
Carrying amount of the Group’s interest in the associate | $ | 66,109 |  |  | $ | 67,396 |
| 2025 |  | 2024
Other income | $ | 86 |  |  | $ | 31 |
Other gains or losses | 266 |  |  | — |
Interest income | 3,467 |  |  | 4,775 |
Depreciation and amortization | (5,082) |  |  | (5,677) |
Other expenses | (3,174) |  |  | (4,459) |
Income tax expense | 836 |  |  | 841 |
Loss for the year | $ | (3,601) |  |  | $ | (4,489) |
Item that may be reclassified subsequently to profit or loss: |  |  |
Exchange differences on translation of foreign operations | (75) |  |  | 597 |
Total comprehensive expense for the year | $ | (3,676) |  |  | $ | (3,892) |
Group's share of loss and total comprehensive expense | $ | (1,286) |  |  | $ | (1,707) |
Dividends received by the Group | $ | — |  |  | $ | — |
Disclosure of detailed information about disposals | This transaction has resulted in the recognition of a gain in profit or loss, calculated as follows:
| 2024
Proceeds of disposal | $ | 30,000 |
Fair value of interest retained - 35% | 67,954 |
Carrying amount of interest on the date of disposal | (96,710) |
Gain recognized | $ | 1,244 |
Summary of detailed information about financial information of associates | Aggregate information of associates that are not individually material:
| 2025 |  | 2024
Carrying amount of interest in CERBACT | $ | — |  |  | $ | 827 |
Group's share of (loss)/profit and total comprehensive (expense)/income | (868) |  |  | 231 |

X
- Definition The disclosure of interests in associates. [Refer: Total for all associates [member]] + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 12 -IssueDate 2025-01-01 -Paragraph 2 -Subparagraph b -Clause ii -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2025-en-r&anchor=para_2_b_ii&doctype=Standard -URIDate 2025-03-27 + Details
Name: | ifrs-full_DisclosureOfInterestsInAssociatesExplanatory
Namespace Prefix: | ifrs-full_
Data Type: | dtr-2022:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesAbstract
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Disclosure Of Detailed Information About Changes In Ownership Interest + References No definition available. + Details
Name: | pre_DisclosureOfDetailedInformationAboutChangesInOwnershipInterestTableTextBlock
Namespace Prefix: | pre_
Data Type: | dtr-types1:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Disclosure Of Detailed Information About Financial Information Of Associates Explanatory + References No definition available. + Details
Name: | pre_DisclosureOfDetailedInformationAboutFinancialInformationOfAssociatesExplanatoryTableTextBlock
Namespace Prefix: | pre_
Data Type: | dtr-types1:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Disclosure Of Detailed Information About Interest In Equity Method Investments + References No definition available. + Details
Name: | pre_DisclosureOfDetailedInformationAboutInterestInEquityMethodInvestmentsTableTextBlock
Namespace Prefix: | pre_
Data Type: | dtr-types1:textBlockItemType
Balance Type: | na
Period Type: | duration